The field of cognitive neuroscience has been making noticeable strides in the investigation of treatments for mild cognitive impairment (MCI), an intermediary stage between normal cognitive decline and more serious conditions such as Alzheimer's. The growing body of research signifies an attempt to understand MCI, identify its underlying causes and...
Discover more insightsIn recent years, the pharmaceutical sector has seen increased investment in neurodegenerative therapeutics. This is largely due to the rising prevalence of conditions such as Alzheimer's and dementia, which has created a pronounced demand for effective treatments. Currently, the trend is towards precision medicine, as a more personalized approach offers...
Discover more insightsThe focus on treatment of Lewy Body Dementia (LBD) has begun to increase significantly in the neurology healthcare sector due to the prevalence of the disease. However, the path towards the creation of feasible therapeutic solutions is not without its share of challenges. These include issues pertaining to complex diagnosis,...
Discover more insights